Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma

Molecular classification of IDH-mutant glioblastomas based on gene expression profiles

(2019) Fan Wu et al.   CARCINOGENESIS

m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas

(2019) Rui-Chao Chai et al.   Aging-US

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

(2018) Mitsuaki Shirahata et al.   ACTA NEUROPATHOLOGICA

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment

(2018) Amelie Griveau et al.   CANCER CELL

LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer

(2018) Kai Zhao et al.   CARCINOGENESIS

Relapse pathway of glioblastoma revealed by single-cell molecular analysis

(2018) Xuelian Chen et al.   CARCINOGENESIS

A novel prognostic six-CpG signature in glioblastomas

(2018) An-An Yin et al.   CNS Neuroscience & Therapeutics

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

(2018) Y. Gao et al.   EUROPEAN JOURNAL OF CANCER

Glioma infiltration and extracellular matrix: key players and modulators

(2018) Valéria Pereira Ferrer et al.   GLIA

High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts

(2018) Allan Lipton et al.   INTERNATIONAL JOURNAL OF CANCER

A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma

(2018) Ruichao Chai et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Endothelial trans-differentiation in glioblastoma recurring after radiotherapy

(2018) Ivana De Pascalis et al.   MODERN PATHOLOGY

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

(2018) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma

(2018) Zhengui Zhou et al.   Aging-US

A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas

(2018) Rui-Chao Chai et al.   MODERN PATHOLOGY

Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence

(2017) Federica Ganci et al.   MODERN PATHOLOGY

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

(2017) Kosuke Aoki et al.   NEURO-ONCOLOGY

Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma

(2017) Xin Hu et al.   NEURO-ONCOLOGY

Adult IDH wild-type lower-grade gliomas should be further stratified

(2017) Abudumijit Aibaidula et al.   NEURO-ONCOLOGY

Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation

(2017) Andrea E. Calvert et al.   Cell Reports

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

CGCG clinical practice guidelines for the management of adult diffuse gliomas

(2016) Tao Jiang et al.   CANCER LETTERS

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

(2016) Michele Ceccarelli et al.   CELL

Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas

(2016) Pei Yang et al.   NEURO-ONCOLOGY

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

(2016) Jan C. Buckner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas

(2016) Aurélie Kamoun et al.   Nature Communications

Brain tumour cells interconnect to a functional and resistant network

(2015) Matthias Osswald et al.   NATURE

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras

(2014) Zhumei Shi et al.   NEURO-ONCOLOGY

A glioma classification scheme based on coexpression modules of EGFR and PDGFRA

(2014) Yingyu Sun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management

(2013) Yongzhi Wang et al.   CANCER LETTERS

AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries

(2013) Rui Chao Chai et al.   GLIA

Initial treatment patterns over time for anaplastic oligodendroglial tumors

(2012) K. S. Panageas et al.   NEURO-ONCOLOGY

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

(2012) Wei Yan et al.   NEURO-ONCOLOGY

Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma

(2010) Soumya AM Rao et al.   MODERN PATHOLOGY